Creative Edge Nutrition, Inc.’s (OTC: FITX) partially-owned subsidiary, CEN Biotech Inc., will be holding an open house for shareholders at its new location in Lakeshore, Ontario. The subsidiary was created solely purpose of supplying the Canadian public with completely legal pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR) governing cannabis production and sale.

Unlike MediSwipe Inc. (OTC: MWIP) or HEMP Inc. (OTC: HEMP), CEN Biotech will be involved in the actual production and sale of medical marijuana in Canada, potentially making it one of the only U.S.-traded pure-plays in the industry. The company anticipates growing 1.3 million pounds of cannabis per year with a selling price of about $8 per gram and 80-87% profit margins which means that investors could see a robust $5 billion run rate.

Read the entire press release discussing the open house here:

Creative Edge Nutrition, Inc. (PINKSHEETS: FITX), is proud to announce that it is having shareholder open house. Shareholders may use this press release as a Letter of Invitation for Canada Customs and Border Services Agency.

To Whom It May Concern:

Please accept this invitation letter to attend an Open House at the new location of CEN Biotech Inc., on Friday February 21, 2014 at 5:00pm and Saturday February 22, 2014 at 10:00am.

We are located at 20 North Rear Rd., Lakeshore, Ontario, Canada N0R 1K0, just south of the Manning Rd. interchange on Highway 401.

Please dress appropriate for the weather and we look forward to meeting you at the Open House.

Sincerely Yours,
Bill Chaaban
President & CEO

Bill Chaaban, President and CEO stated, “We are very excited to meet our shareholders face to face and show them our plans in person. We intentionally scheduled the press conference after market hours so we may press release anything disseminated to our complete shareholder base and prospective shareholders before the open of market on Monday February 24, 2014. We are very excited to welcome you to Lakeshore, Ontario and our site. We have exciting times ahead as we forge forward with executing our plans of building the world’s largest and most technologically advanced medical marijuana facility in Lakeshore, Ontario, Canada.”

About CEN Biotech

CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR) CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.

Cautionary Language Concerning Forward-Looking Statements

This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for Creative Edge Nutrition’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in Creative Edge Nutrition’s filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting Creative Edge Nutrition Inc. please refer to the Company’s Securities and Exchange Commission filings, which are available at Creative Edge Nutrition Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: Jeff Thomas (313) 655-1669 Email: [email protected]